served lower cognitive function scores among those with higher WMHL volumes [4] . Most prior WMHL studies have occurred in the elderly or in populations with dementia [5] . The extent to which WMHL progression and decline in cognitive function occur in a quiescent preclinical state in healthy middle-aged persons remains unknown [6, 7] . We determined the progression of silent WMHL and changes in cognitive function over 5 years in a random sample of 20 healthy relatives (aged 50-59) years of patients with coronary artery disease <60 years of age (one subject per family). Persons with any serious physical or psychiatric morbidity, neurological disease, cardiovascular disease, and diabetes were excluded.

